Ranbaxy Australia Pty Ltd v Warner-Lambert Company LLC [2006] FCA 1353
The foreign patent office communications and related documents were inadmissible because they were sought to be used on the only identified issue, construction of the Basic Patent, and amounted to opinions, submissions or evidence of intentions of the patentee or its agents. Their admissibility was not established by Ranbaxy's desire to contradict expert evidence. In any event, the Court would exclude the material under s 135(c) of the Evidence Act 1995 (Cth) because it raised a collateral issue likely to cause undue waste of Court time for little or no reward.
- Jurisdiction
- Australia
- Judgment Date
- 09 October 2006
- Procedural Posture
- Ruling on Evidence in Patent Proceedings / Objection to Admissibility of Affidavit Passages and Documents
- Outcome
- Warner-Lambert's objections were upheld and the identified affidavit paragraphs and documents were ruled inadmissible.
- Legal Topics
- ['admissibility of Evidence' 'patent Construction' 'patent Office Communications' 'foreign Patent Prosecution Documents' 'affidavit Evidence' 'evidence Act 1995 (cth) S 135(c)']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Ruling on Evidence in Patent Proceedings / Objection to Admissibility of Affidavit Passages and Documents
Legal Issues
- 1 ['Whether communications between Warner-Lambert or its agents and foreign patent offices were admissible as an aid to construction of Australian Letters Patent No 601981.' 'Whether the documents were admissible to rebut expert evidence that the Basic Patent would not be understood as limited to racemic mixtures only.' 'Whether the material should in any event be excluded under s 135(c) of the Evidence Act 1995 (Cth).']
Ratio Decidendi
The foreign patent office communications and related documents were inadmissible because they were sought to be used on the only identified issue, construction of the Basic Patent, and amounted to opinions, submissions or evidence of intentions of the patentee or its agents. Their admissibility was not established by Ranbaxy's desire to contradict expert evidence. In any event, the Court would exclude the material under s 135(c) of the Evidence Act 1995 (Cth) because it raised a collateral issue likely to cause undue waste of Court time for little or no reward.
Court Disposition
Warner-Lambert's objections were upheld and the identified affidavit paragraphs and documents were ruled inadmissible.
Orders
- ["Paragraphs 4, 6 and 7 of Mr Tye's first affidavit, paragraphs 20 to 28 of his second affidavit and paragraphs 5 to 7 of his third affidavit, and the documents referred to therein, are inadmissible."]
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment